Sign in
4

Changes in Ownership

Dermata Therapeutics, Inc. Filed Acc 0000905718-21-001098

Chief Financial Officer acquired 4,581 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
INSLEY THOMAS Chief Financial Officer 2021-08-17 Conversion +4,581 14,337 I
Derivatives
INSLEY THOMAS Chief Financial Officer 2021-08-17 Conversion · Series 1d Preferred Stock −30,910 0 I
Loading xslF345X03/dermata_fm4aug172021.xml…